InMed Pharmaceuticals, a clinical stage biotech developing cannabinoid-based products, raised $8 million by offering 1.8 million shares at $4.50. The company also offered warrants to purchase 1.8 million shares of common stock at an exercise price of $4.50. At...read more
InMed Pharmaceuticals, a clinical stage biotech developing cannabinoid-based products, announced terms for its IPO on Thursday. The Vancouver, Canada-based company plans to raise $10 million by offering 2.4 million shares at $4.13, above the last close of...read more
Updated Monday, 7/6. Following the long weekend, two Chinese IPOs, two biotechs, and a SPAC are currently scheduled to list in the US in the week ahead, inlcuding China’s largest LGBTQ dating app BlueCity (BLCT). More...read more
Five IPOs and one SPAC went public this past week led by Royalty Pharma (RPRX), which completed the largest US IPO of 2020 to date. Healthcare continued to dominate, with all five IPOs coming from the sector. Royalty Pharma (RPRX)...read more
Canadian nano-cap InMed Pharmaceuticals prices Nasdaq uplisting at $4.50
InMed Pharmaceuticals, a clinical stage biotech developing cannabinoid-based products, raised $8 million by offering 1.8 million shares at $4.50. The company also offered warrants to purchase 1.8 million shares of common stock at an exercise price of $4.50. At...read more
Canadian nano-cap biotech InMed Pharmaceuticals sets terms for $10 million Nasdaq uplisting
InMed Pharmaceuticals, a clinical stage biotech developing cannabinoid-based products, announced terms for its IPO on Thursday. The Vancouver, Canada-based company plans to raise $10 million by offering 2.4 million shares at $4.13, above the last close of...read more
US IPO Week Ahead: Third quarter kicks off with China’s largest gay dating app
Updated Monday, 7/6. Following the long weekend, two Chinese IPOs, two biotechs, and a SPAC are currently scheduled to list in the US in the week ahead, inlcuding China’s largest LGBTQ dating app BlueCity (BLCT). More...read more
US IPO Weekly Recap: Royalty Pharma takes the crown in 5 IPO week
Five IPOs and one SPAC went public this past week led by Royalty Pharma (RPRX), which completed the largest US IPO of 2020 to date. Healthcare continued to dominate, with all five IPOs coming from the sector. Royalty Pharma (RPRX)...read more